Oxygen nanobubbles revert hypoxia by methylation programming

Pushpak N. Bhandari, Yi Cui, Bennett D. Elzey, Craig J. Goergen, Christopher M. Long, Joseph Irudayaraj

Research output: Contribution to journalArticle

Abstract

Targeting the hypoxic tumor microenvironment has a broad impact in cancer epigenetics and therapeutics. Oxygen encapsulated nanosize carboxymethyl cellulosic nanobubbles were developed for mitigating the hypoxic regions of tumors to weaken the hypoxia-driven pathways and inhibit tumor growth. We show that 5-methylcytosine (5mC) hypomethylation in hypoxic regions of a tumor can be reverted to enhance cancer treatment by epigenetic regulation, using oxygen nanobubbles in the sub-100 nm size range, both, in vitro and in vivo. Oxygen nanobubbles were effective in significantly delaying tumor progression and improving survival rates in mice models. Further, significant hypermethylation was observed in promoter DNA region of BRCA1 due to oxygen nanobubble (ONB) treatment. The nanobubbles can also reprogram several hypoxia associated and tumor suppressor genes such as MAT2A and PDK-1, in addition to serving as an ultrasound contrast agent. Our approach to develop nanosized oxygen encapsulated bubbles as an ultrasound contrast agent for methylation reversal is expected to have a significant impact in epigenetic programming and to serve as an adjuvant to cancer treatment.

Original languageEnglish (US)
Article number9268
JournalScientific reports
Volume7
Issue number1
DOIs
StatePublished - Dec 1 2017
Externally publishedYes

Fingerprint

Methylation
Oxygen
Neoplasms
Epigenomics
Contrast Media
5-Methylcytosine
Tumor Microenvironment
Hypoxia
Tumor Suppressor Genes
Genetic Promoter Regions
DNA
Growth

ASJC Scopus subject areas

  • General

Cite this

Bhandari, P. N., Cui, Y., Elzey, B. D., Goergen, C. J., Long, C. M., & Irudayaraj, J. (2017). Oxygen nanobubbles revert hypoxia by methylation programming. Scientific reports, 7(1), [9268]. https://doi.org/10.1038/s41598-017-08988-7

Oxygen nanobubbles revert hypoxia by methylation programming. / Bhandari, Pushpak N.; Cui, Yi; Elzey, Bennett D.; Goergen, Craig J.; Long, Christopher M.; Irudayaraj, Joseph.

In: Scientific reports, Vol. 7, No. 1, 9268, 01.12.2017.

Research output: Contribution to journalArticle

Bhandari, Pushpak N. ; Cui, Yi ; Elzey, Bennett D. ; Goergen, Craig J. ; Long, Christopher M. ; Irudayaraj, Joseph. / Oxygen nanobubbles revert hypoxia by methylation programming. In: Scientific reports. 2017 ; Vol. 7, No. 1.
@article{fb1ac85d8a674dbca3dfe3c3cfc5c98d,
title = "Oxygen nanobubbles revert hypoxia by methylation programming",
abstract = "Targeting the hypoxic tumor microenvironment has a broad impact in cancer epigenetics and therapeutics. Oxygen encapsulated nanosize carboxymethyl cellulosic nanobubbles were developed for mitigating the hypoxic regions of tumors to weaken the hypoxia-driven pathways and inhibit tumor growth. We show that 5-methylcytosine (5mC) hypomethylation in hypoxic regions of a tumor can be reverted to enhance cancer treatment by epigenetic regulation, using oxygen nanobubbles in the sub-100 nm size range, both, in vitro and in vivo. Oxygen nanobubbles were effective in significantly delaying tumor progression and improving survival rates in mice models. Further, significant hypermethylation was observed in promoter DNA region of BRCA1 due to oxygen nanobubble (ONB) treatment. The nanobubbles can also reprogram several hypoxia associated and tumor suppressor genes such as MAT2A and PDK-1, in addition to serving as an ultrasound contrast agent. Our approach to develop nanosized oxygen encapsulated bubbles as an ultrasound contrast agent for methylation reversal is expected to have a significant impact in epigenetic programming and to serve as an adjuvant to cancer treatment.",
author = "Bhandari, {Pushpak N.} and Yi Cui and Elzey, {Bennett D.} and Goergen, {Craig J.} and Long, {Christopher M.} and Joseph Irudayaraj",
year = "2017",
month = "12",
day = "1",
doi = "10.1038/s41598-017-08988-7",
language = "English (US)",
volume = "7",
journal = "Scientific Reports",
issn = "2045-2322",
publisher = "Nature Publishing Group",
number = "1",

}

TY - JOUR

T1 - Oxygen nanobubbles revert hypoxia by methylation programming

AU - Bhandari, Pushpak N.

AU - Cui, Yi

AU - Elzey, Bennett D.

AU - Goergen, Craig J.

AU - Long, Christopher M.

AU - Irudayaraj, Joseph

PY - 2017/12/1

Y1 - 2017/12/1

N2 - Targeting the hypoxic tumor microenvironment has a broad impact in cancer epigenetics and therapeutics. Oxygen encapsulated nanosize carboxymethyl cellulosic nanobubbles were developed for mitigating the hypoxic regions of tumors to weaken the hypoxia-driven pathways and inhibit tumor growth. We show that 5-methylcytosine (5mC) hypomethylation in hypoxic regions of a tumor can be reverted to enhance cancer treatment by epigenetic regulation, using oxygen nanobubbles in the sub-100 nm size range, both, in vitro and in vivo. Oxygen nanobubbles were effective in significantly delaying tumor progression and improving survival rates in mice models. Further, significant hypermethylation was observed in promoter DNA region of BRCA1 due to oxygen nanobubble (ONB) treatment. The nanobubbles can also reprogram several hypoxia associated and tumor suppressor genes such as MAT2A and PDK-1, in addition to serving as an ultrasound contrast agent. Our approach to develop nanosized oxygen encapsulated bubbles as an ultrasound contrast agent for methylation reversal is expected to have a significant impact in epigenetic programming and to serve as an adjuvant to cancer treatment.

AB - Targeting the hypoxic tumor microenvironment has a broad impact in cancer epigenetics and therapeutics. Oxygen encapsulated nanosize carboxymethyl cellulosic nanobubbles were developed for mitigating the hypoxic regions of tumors to weaken the hypoxia-driven pathways and inhibit tumor growth. We show that 5-methylcytosine (5mC) hypomethylation in hypoxic regions of a tumor can be reverted to enhance cancer treatment by epigenetic regulation, using oxygen nanobubbles in the sub-100 nm size range, both, in vitro and in vivo. Oxygen nanobubbles were effective in significantly delaying tumor progression and improving survival rates in mice models. Further, significant hypermethylation was observed in promoter DNA region of BRCA1 due to oxygen nanobubble (ONB) treatment. The nanobubbles can also reprogram several hypoxia associated and tumor suppressor genes such as MAT2A and PDK-1, in addition to serving as an ultrasound contrast agent. Our approach to develop nanosized oxygen encapsulated bubbles as an ultrasound contrast agent for methylation reversal is expected to have a significant impact in epigenetic programming and to serve as an adjuvant to cancer treatment.

UR - http://www.scopus.com/inward/record.url?scp=85028047984&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85028047984&partnerID=8YFLogxK

U2 - 10.1038/s41598-017-08988-7

DO - 10.1038/s41598-017-08988-7

M3 - Article

C2 - 28839175

AN - SCOPUS:85028047984

VL - 7

JO - Scientific Reports

JF - Scientific Reports

SN - 2045-2322

IS - 1

M1 - 9268

ER -